Research Roundup: Viral hepatitis, treatment for persistent Ebola, E. coli–based vaccines
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Sign up to receive news and updates from GHTC.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
GHTC breaks down the status of R&D for vaccines, drugs, and diagnostics against yellow fever.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
GHTC member the International Partnership for Microbicides (IPM) announced last week the results of two phase 3 clinical trials demonstrating that a monthly vaginal ring filled with the antiretroviral drug dapivirine can reduce the risk of HIV infection in women.